IIROC Trade Resumption - BETR

Trading resumes in:

Company: BetterLife Pharma Inc.

CSE Symbol: BETR

All Issues: Yes

Resumption (ET): 11:15 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada .

SOURCE Investment Industry Regulatory Organization of Canada (IIROC)

View original content: https://www.newswire.ca/en/releases/archive/December2021/22/c5557.html

News Provided by Canada Newswire via QuoteMedia

cse:betrpharmaceutical investing
BETR:CNX
The Conversation (0)
InMed Provides Update on BayMedica Commercial Business

InMed Provides Update on BayMedica Commercial Business

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today released the following statement.Recently, H.R. 5371, the "Continuing... Keep Reading...
Thian Chew, CEO of Invion

Invion Advances Global Strategy With New Licencing Agreement

Invion (ASX:IVX) has taken a major step forward with a new global licencing agreement that streamlines its rights across key cancer and infectious disease programs. The move gives the company a clearer path to advance its Photosoft technology, expand market opportunities and strengthen... Keep Reading...
Blank pill bottle spilling a variety of pharmaceutical pills and capsules.

5 Biggest Pharmaceutical ETFs in 2025

The global pharmaceutical market is set to surpass a total value of US$1.75 trillion by the end of the decade, according to Evaluate Pharma.Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma... Keep Reading...
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

Data demonstrate a favorable bioavailability profile of INM-901 oral formulationData will support design and planning of first in human clinical trialsPreparing for pre-IND meeting with the FDA InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company... Keep Reading...
InMed Pharmaceuticals (NASDAQ:INM)

InMed Pharmaceuticals

Keep Reading...
Canada maple leaves on left and pharmaceutical pills in red and blue on right.

4 Best-performing Canadian Pharma Stocks of 2025

From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic.Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are... Keep Reading...

Latest News

Latest Press Releases

Discovery of New Parallel Silver Lode at Webbs

Ultra High-Grades Returned in Burbanks Phase 1 Drilling

Trading Halt

Titanium-Vanadium-Magnetite Discovery Extended over 1km

Related News

Battery Metals Investing

Discovery of New Parallel Silver Lode at Webbs

Precious Metals Investing

Ultra High-Grades Returned in Burbanks Phase 1 Drilling

Battery Metals Investing

Titanium-Vanadium-Magnetite Discovery Extended over 1km

gold investing

Forge Resources Intersects 3.4 g/t Gold over 44.75 Metres, and 800 Metre Step-Out Discovers 1.04 g/t Gold over 55.52 Metres at Alotta, Yukon

Precious Metals Investing

LaFleur Minerals Upsizes LIFE and Flow-Through Unit Offerings

Uranium Investing

Top 4 ASX Uranium Stocks of 2025

Cleantech Investing

Disrupting the Gold Standard: Eyeing Cyanide-free Alternatives in Resource Extraction